UFMylation: A Unique & Fashionable Modification for Life

Ubiquitin-fold modifier 1 (UFM1) is one of the newly-identified ubiquitin-like proteins. Similar to ubiquitin, UFM1 is conjugated to its target proteins by a three-step enzymatic reaction. The UFM1-activating enzyme, ubiquitin-like modifier-activating enzyme 5 (UBA5), serves as the E1 to activate UFM1; UFM1-conjugating enzyme 1 (UFC1) acts as the E2 to transfer the activated UFM1 to the active site of the E2; and the UFM1-specific ligase 1 (UFL1) acts as the E3 to recognize its substrate, transfer, and ligate the UFM1 from E2 to the substrate. This process is called ufmylation. UFM1 chains can be cleaved from its target proteins by UFM1-specific proteases (UfSPs), suggesting that the ufmylation modification is reversible. UFM1 cascade is conserved among nearly all of the eukaryotic organisms, but not in yeast, and associated with several cellular activities including the endoplasmic reticulum stress response and hematopoiesis. Furthermore, the UFM1 cascade is closely related to a series of human diseases. In this review, we summarize the molecular details of this reversible modification process, the recent progress of its functional studies, as well as its implication in tumorigenesis and potential therapeutic targets for cancer.

[1]  S. Gannavaram,et al.  Deletion of mitochondrial associated ubiquitin fold modifier protein Ufm1 in Leishmania donovani results in loss of β‐oxidation of fatty acids and blocks cell division in the amastigote stage , 2012, Molecular microbiology.

[2]  B. O’Malley,et al.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family , 2009, Nature Reviews Cancer.

[3]  C. Ji,et al.  UBE1DC1, an ubiquitin‐activating enzyme, activates two different ubiquitin‐like proteins , 2008, Journal of cellular biochemistry.

[4]  I. Ladunga,et al.  The Small Ubiquitin-Like Modifier (SUMO) and SUMO-Conjugating System of Chlamydomonas reinhardtii , 2008, Genetics.

[5]  H. Liu,et al.  Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form. , 2014, Experimental and molecular pathology.

[6]  M. Madan Babu,et al.  A million peptide motifs for the molecular biologist. , 2014, Molecular cell.

[7]  I. Dikic,et al.  Expanding the ubiquitin code through post‐translational modification , 2015, EMBO reports.

[8]  J. Wade Harper,et al.  Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways , 2009, Nature Reviews Molecular Cell Biology.

[9]  Zhijian J. Chen,et al.  Nonproteolytic functions of ubiquitin in cell signaling. , 2009, Molecular cell.

[10]  Keiji Tanaka,et al.  The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice , 2011, Nature communications.

[11]  B. Schmitz,et al.  Cytoplasmic domain of NCAM140 interacts with ubiquitin-fold modifier-conjugating enzyme-1 (Ufc1). , 2014, Experimental cell research.

[12]  Q. Pang,et al.  Ubiquitin-fold modifier 1 inhibits apoptosis by suppressing the endoplasmic reticulum stress response in Raw264.7 cells. , 2014, International journal of molecular medicine.

[13]  Jianping Liu,et al.  Isolation and Characterization of Ubiquitin-activating Enzyme E1-domain Containing 1, UBE1DC1 , 2005, Molecular Biology Reports.

[14]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[15]  Honglin Li,et al.  A Novel C53/LZAP-interacting Protein Regulates Stability of C53/LZAP and DDRGK Domain-containing Protein 1 (DDRGK1) and Modulates NF-κB Signaling* , 2010, The Journal of Biological Chemistry.

[16]  B. Pace,et al.  RCAD/Ufl1, a Ufm1 E3 ligase, is essential for hematopoietic stem cell function and murine hematopoiesis , 2015, Cell Death and Differentiation.

[17]  Laura A. Crinnion,et al.  Identification of a mutation in the ubiquitin-fold modifier 1-specific peptidase 2 gene, UFSP2, in an extended South African family with Beukes hip dysplasia. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[18]  T. Sixma,et al.  Layers of DUB regulation. , 2015, Trends in biochemical sciences.

[19]  Jong Ho Park,et al.  Ubiquitin-Fold Modifier 1 Acts as a Positive Regulator of Breast Cancer , 2015, Front. Endocrinol..

[20]  M. Granvik,et al.  Ubiquitin Fold Modifier 1 (UFM1) and Its Target UFBP1 Protect Pancreatic Beta Cells from ER Stress-Induced Apoptosis , 2011, PloS one.

[21]  V. Haroutunian,et al.  Dysfunction of the Ubiquitin Proteasome and Ubiquitin-Like Systems in Schizophrenia , 2013, Neuropsychopharmacology.

[22]  R. Kaufman,et al.  The mammalian unfolded protein response. , 2003, Annual review of biochemistry.

[23]  R. Chou,et al.  Targeting post-translational modifications of histones for cancer therapy. , 2015, Cellular and molecular biology.

[24]  Keiji Tanaka,et al.  A novel protein‐conjugating system for Ufm1, a ubiquitin‐fold modifier , 2004, The EMBO journal.

[25]  H. Ovaa,et al.  Two Novel Ubiquitin-fold Modifier 1 (Ufm1)-specific Proteases, UfSP1 and UfSP2* , 2007, Journal of Biological Chemistry.

[26]  S. Jentsch,et al.  Ubiquitin and its kin: how close are the family ties? , 2000, Trends in cell biology.

[27]  A. Vertegaal,et al.  Uncovering Ubiquitin and Ubiquitin-like Signaling Networks , 2011, Chemical reviews.

[28]  Mingsheng Zhang,et al.  Transcriptional Regulation of the Ufm1 Conjugation System in Response to Disturbance of the Endoplasmic Reticulum Homeostasis and Inhibition of Vesicle Trafficking , 2012, PloS one.

[29]  B. Pace,et al.  UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development , 2015, PLoS genetics.

[30]  S. Gannavaram,et al.  Deletion of Ubiquitin Fold Modifier Protein Ufm1 Processing Peptidase Ufsp in L. donovani Abolishes Ufm1 Processing and Alters Pathogenesis , 2014, PLoS neglected tropical diseases.

[31]  Junzhi Zhou,et al.  DDRGK1 Regulates NF-κB Activity by Modulating IκBα Stability , 2013, PloS one.

[32]  E. Liebau,et al.  The Ubiquitin-fold Modifier 1 (Ufm1) Cascade of Caenorhabditis elegans , 2013, The Journal of Biological Chemistry.

[33]  J. Chen,et al.  Post-translational modifications and the Warburg effect , 2014, Oncogene.

[34]  G. Dellaire,et al.  The Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and Repair , 2015, Biomolecules.

[35]  B. Rost,et al.  NMR and X-RAY structures of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1) reveal structural and functional conservation in the metazoan UFM1-UBA5-UFC1 ubiquination pathway , 2009, Journal of Structural and Functional Genomics.

[36]  Nobuhiro Nakamura,et al.  Ubiquitin System , 2018, International journal of molecular sciences.

[37]  M. Glickman,et al.  PCI complexes: Beyond the proteasome, CSN, and eIF3 Troika. , 2009, Molecular cell.

[38]  C. Pickart,et al.  Ubiquitin: structures, functions, mechanisms. , 2004, Biochimica et biophysica acta.

[39]  Mario de Bono,et al.  An ER Complex of ODR-4 and ODR-8/Ufm1 Specific Protease 2 Promotes GPCR Maturation by a Ufm1-Independent Mechanism , 2014, PLoS genetics.

[40]  Jens Daniel,et al.  The Ufm1 Cascade , 2014, Cells.

[41]  L. Rogers,et al.  Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. , 2006, American journal of physiology. Heart and circulatory physiology.

[42]  Howard Riezman,et al.  Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling , 2007, Science.

[43]  D. Noh,et al.  Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development. , 2014, Molecular cell.

[44]  D. Finley,et al.  Recognition and processing of ubiquitin-protein conjugates by the proteasome. , 2009, Annual review of biochemistry.

[45]  M. Kasahara,et al.  A Novel Type of E3 Ligase for the Ufm1 Conjugation System* , 2009, The Journal of Biological Chemistry.